Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 - CISMeF
Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11NCIt concept
Preferred Label : Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11;
NCIt synonyms : Acute Myeloid Leukemia with Abnormal Marrow Eosinophils; Acute Myeloid Leukemia, CBFB-MYH11; Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB::MYH11; Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB::MYH11
Fusion; Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 Fusion; Acute Myeloid Leukemia, CBF-beta/MYH11;
NCIt related terms : AML with inv(16)(p13q22) or t(16;16) (p13.1;q22), (CBFB/MYH11); AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11;
NCIt definition : An acute myeloid leukemia with monocytic and granulocytic differentiation and the
presence of a characteristically abnormal eosinophil component in the bone marrow.
This type of acute myeloid leukemia has a favorable prognosis. (WHO, 2001);
Alternative definition : NICHD: Acute myeloid leukemia characterized by the presence of abnormal bone marrow
eosinophils and the characteristic cytogenetic abnormality inv(16)(p13.1q22) or t(16;16)(p13.1;q22),
which results in the expression of the fusion protein CBFB-MYH11. This is seen in
7-9% of children with AML.;